







NeuroPolyGen was founded in the early decades of the 21st century, when healthcare systems began facing a new and unexplained challenge.

We are developing standardized medical protocols to detect and monitor patients presenting with unexplained cutaneous anomalies associated with environmental exposure.

Through advanced imaging technologies (MRI, PET, spectroscopy), we are mapping the integration of synthetic particles within human tissues.

Our research explores how polymeric structures fuse with human cells, unlocking potential therapies for regenerative medicine.

We investigate the role of marine ecosystems as vectors of mutated microplastic exposure and their impact on coastal populations.

Several patients have demonstrated increased sensitivity to electromagnetic fields and subtle vibrational patterns. Our teams are studying this phenomenon to develop next-generation sensory interfaces.

Inspired by hybrid skin structures, our dermatological research seeks applications in resilience, flexibility, and novel forms of protective tissue.


At NeuroPolyGen, we operate at the frontier of biotechnology, neuroscience, and synthetic biology.
Our mission is to transform today’s health challenges into opportunities for innovation and resilience.
NeuroPolyGen emerged as a response. A consortium of physicians, neuroscientists, and molecular biologists joined forces with one mission: to study, diagnose, and create solutions for the invisible crisis reshaping humanity at its core.
